Defining sedation-related adverse events in the pediatric intensive care unit

Mary Jo C Grant1, Michele C Balas, Martha A Q Curley

  • 1Pediatric Critical Care, Primary Children's Medical Center, 100 North Mario Capecchi Drive, Salt Lake City, UT 84113, USA. maryjo.grant@imail.org

Insights

This study defines and estimates rates of adverse events (AE) related to sedation in pediatric intensive care units (ICUs). These findings are crucial for improving patient safety and guiding future clinical trials in pediatric sedation management.

Area of Science:

  • Pediatric Critical Care Medicine
  • Pharmacology
  • Patient Safety

Background:

  • Optimal sedation management is critical for critically ill pediatric patients.
  • Standardized definitions of sedation-related adverse events (AE) are needed for research.
  • Improving short- and long-term outcomes requires better understanding of pediatric sedation AEs.

Purpose of the Study:

  • To systematically review and define sedation-related AEs in pediatric ICUs.
  • To estimate the incidence rates of these AEs in the pediatric population.
  • To provide standardized definitions for use in multicenter clinical trials.

Main Methods:

  • A multiphase systematic literature review was conducted.
  • Databases searched included OVID-MEDLINE and CINAHL (1998-2012).
  • Key terms focused on sedation and intensive/critical care in pediatric populations.

Main Results:

  • Eleven sedation-related adverse events were identified and operationally defined.
  • Pediatric-specific event rates were derived from 64 articles.
  • Identified AEs include inadequate sedation/pain management, withdrawal, extubation failure, VAP, and pressure ulcers.

Conclusions:

  • Operational definitions and event rates for pediatric sedation-related AEs are now available.
  • Standardized reporting of these AEs will enhance patient safety.
  • This work supports the development of evidence-based sedation guidelines for pediatric ICUs.
Abstract

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...